Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals
- PMID: 28422785
- DOI: 10.1097/COH.0000000000000357
Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals
Abstract
Purpose of review: Increased body of evidence gathered over time indicate that antibodies are capable of many inhibitory mechanisms, virus neutralization being just one of them. Nonneutralizing antibodyactivities interfering with HIV replication can also lead to a decrease in viral load and even in-vivo protection.
Recent findings: It was previously believed that neutralizing antibodies can achieve sterilizing protection mainly by using their neutralization capacities against the infecting virus directly at the portal of virus entry. Recent findings show that protection can be obtained by neutralizing antibodiesat distal sites of virus challenge. In this case, foci of virus infection that escaped from initial inhibition of virus are eliminated presumably by additional nonneutralizing antibody activities. These data inexorably strengthen the diverse functions of antibodies and broaden their role as antiviral mediator.
Summary: The review summarizes the current knowledge and the difficulties to encompass the numerous functions of antibodies. A complete understanding of the various facets of antibody functions is required to efficiently induce them via next-generation vaccine design.
Similar articles
-
Broadly neutralizing antibodies against HIV-1: templates for a vaccine.Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Virology. 2013. PMID: 23217615 Review.
-
The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development.Expert Rev Vaccines. 2014 Dec;13(12):1489-500. doi: 10.1586/14760584.2014.951335. Epub 2014 Aug 28. Expert Rev Vaccines. 2014. PMID: 25163695 Review.
-
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11. J Virol. 2015. PMID: 25673728 Free PMC article.
-
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15. J Virol. 2016. PMID: 26763999 Free PMC article.
-
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.Curr Opin HIV AIDS. 2017 May;12(3):229-240. doi: 10.1097/COH.0000000000000360. Curr Opin HIV AIDS. 2017. PMID: 28422787 Free PMC article. Review.
Cited by
-
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019. Front Immunol. 2019. PMID: 31921207 Free PMC article. Review.
-
Non-neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice.Eur J Immunol. 2021 Jun;51(6):1423-1435. doi: 10.1002/eji.202049068. Epub 2021 Feb 19. Eur J Immunol. 2021. PMID: 33547634 Free PMC article.
-
Antibody responses to viral infections: a structural perspective across three different enveloped viruses.Nat Microbiol. 2019 May;4(5):734-747. doi: 10.1038/s41564-019-0392-y. Epub 2019 Mar 18. Nat Microbiol. 2019. PMID: 30886356 Free PMC article. Review.
-
Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?Front Immunol. 2021 May 4;12:656894. doi: 10.3389/fimmu.2021.656894. eCollection 2021. Front Immunol. 2021. PMID: 34017334 Free PMC article. Review.
-
Non-Neutralizing Antibodies Directed against HIV and Their Functions.Front Immunol. 2017 Nov 20;8:1590. doi: 10.3389/fimmu.2017.01590. eCollection 2017. Front Immunol. 2017. PMID: 29209323 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials